Skip to main content

Interchange Capital Partners, LLC

Position in GILD — Gilead Sciences, Inc.

CIK 1845998 PITTSBURGH, PA

Position in GILD

as of Jun 30, 2026 · filed Jul 20, 2026
Position Value
$681,604
+$255,969 QoQ
Shares Held
5,395
+76.7% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.21%
of 13F equity value
Holder Rank
#1,242
of 2,266 holders
Holding Since
Dec 2020
10 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in GILD Over Time

Shares Held

Position Value (USD)

Derivatives in GILD

reported options exposure · as of Dec 31, 2024
CallValue
$138,555
CallShares
1,500
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

Interchange Capital Partners, LLC holds $15,658,756 across 10 Drug Manufacturers - General names. GILD ranks #7 (4.4% of the industry book) .

# Ticker Company Shares Value (USD) Open
7 GILD
Gilead Sciences, Inc.
This page
5,395 $681,604

All Filings in GILD

Export CSV
14 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $681,604 5,395
2026-03-31 $425,635 3,054
2025-12-31 $510,598 4,160
2025-09-30 $345,321 3,111
2025-03-31 $211,550 1,888
2024-12-31 $171,623 1,858
2024-12-31 $138,555 1,500
2024-09-30 $125,760 1,500
2024-09-30 $155,774 1,858
2024-06-30 $162,537 2,369
2024-06-30 $102,915 1,500
2023-03-31 $24,891 300
2023-03-31 $256,875 3,096
2020-12-31 $121,646 2,088